Alaunos Return On Equity from 2010 to 2024
| TCRT Stock | USD 1.09 0.04 3.81% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (5.57) | Current Value (5.29) | Quarterly Volatility 2.56894762 |
Check Alaunos Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alaunos main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Selling And Marketing Expenses of 4.1 M or Total Revenue of 4.8 K, as well as many exotic indicators such as Price To Sales Ratio of 3.2 K, Dividend Yield of 0.0 or PTB Ratio of 2.82. Alaunos financial statements analysis is a perfect complement when working with Alaunos Therapeutics Valuation or Volatility modules.
Alaunos | Return On Equity |
Latest Alaunos Therapeutics' Return On Equity Growth Pattern
Below is the plot of the Return On Equity of Alaunos Therapeutics over the last few years. Return on Equity is the amount of Alaunos Therapeutics net income returned as a percentage of Alaunos Therapeutics equity. Return on equity measures Alaunos Therapeutics profitability by revealing how much profit Alaunos Therapeutics generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Alaunos Therapeutics' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alaunos Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -1.57 | 10 Years Trend |
|
Return On Equity |
| Timeline |
Alaunos Return On Equity Regression Statistics
| Arithmetic Mean | (0.98) | |
| Geometric Mean | 1.51 | |
| Coefficient Of Variation | (261.60) | |
| Mean Deviation | 1.56 | |
| Median | (0.98) | |
| Standard Deviation | 2.57 | |
| Sample Variance | 6.60 | |
| Range | 10.7776 | |
| R-Value | (0.62) | |
| Mean Square Error | 4.36 | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | (0.36) | |
| Total Sum of Squares | 92.39 |
Alaunos Return On Equity History
About Alaunos Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Alaunos Therapeutics income statement, its balance sheet, and the statement of cash flows. Alaunos Therapeutics investors use historical funamental indicators, such as Alaunos Therapeutics's Return On Equity, to determine how well the company is positioned to perform in the future. Although Alaunos Therapeutics investors may use each financial statement separately, they are all related. The changes in Alaunos Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alaunos Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alaunos Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alaunos Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (5.57) | (5.29) |
Pair Trading with Alaunos Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alaunos Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alaunos Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Alaunos Stock
| 0.85 | EQ | Equillium | PairCorr |
Moving against Alaunos Stock
| 0.53 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Alaunos Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alaunos Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alaunos Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alaunos Therapeutics to buy it.
The correlation of Alaunos Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alaunos Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alaunos Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alaunos Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Alaunos Therapeutics Correlation against competitors. For more information on how to buy Alaunos Stock please use our How to Invest in Alaunos Therapeutics guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Alaunos Stock analysis
When running Alaunos Therapeutics' price analysis, check to measure Alaunos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alaunos Therapeutics is operating at the current time. Most of Alaunos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alaunos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alaunos Therapeutics' price. Additionally, you may evaluate how the addition of Alaunos Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Alaunos Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alaunos Therapeutics. If investors know Alaunos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alaunos Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (32.48) | Quarterly Revenue Growth (0.91) | Return On Assets (0.49) | Return On Equity (1.57) |
The market value of Alaunos Therapeutics is measured differently than its book value, which is the value of Alaunos that is recorded on the company's balance sheet. Investors also form their own opinion of Alaunos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alaunos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alaunos Therapeutics' market value can be influenced by many factors that don't directly affect Alaunos Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alaunos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alaunos Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alaunos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.